$1,016/Day in Crypto - Witness the Proven Strategy Now
Last chance! The "365x Return in 90 Days" crypto Workshop replay disappears this [DAY]. Discover the simple, 92%-win-rate system that turned $250 into $91,457-no charts, no stress.
House Republicans race toward a final vote on Trump's tax bill, daring critics to oppose
WASHINGTON (AP) — Republican leaders in the House are sprinting toward a Wednesday vote on President Donald Trump's , determined to seize momentum from a in the Senate while essentially daring members to defy their party's leader and vote against it.
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
WASHINGTON (AP) — The working under Health Secretary recently of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday.
Buffett Tells Trustee to Put 90% of Money in This One Stock? - Ad
In a surprising move, Warren Buffett (the world's greatest investor, whose firm returned more than 5,000,000% gains), has instructed his trustee to put 90% of his personal money into one stock investment. Buffett says regular folks should be in this stock, too. A CPA and member of the Global CFA Institute explains how to use this stock to optimize your holdings.
Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons
House Judiciary subpoenas ex-Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election.
Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem
Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and halted pipeline programs.
$1,016/Day in Crypto - Witness the Proven Strategy Now - Ad
Last chance! The "365x Return in 90 Days" crypto Workshop replay disappears this [DAY]. Discover the simple, 92%-win-rate system that turned $250 into $91,457-no charts, no stress.
Federal judge reverses rule that would have removed medical debt from credit reports
NEW YORK (AP) — A federal judge in Texas removed a Biden-era finalized ruled by the that would have removed from credit reports.
Republicans are considering changes to Trump's request for $9.4 billion in spending cuts
WASHINGTON (AP) — Senate Republicans were exploring changes Tuesday to President Donald Trump's to cancel $9.4 billion in previously approved spending targeted by his Department of Government Efficiency, signaling potential difficulties ahead of an important test vote.
Stunning Trump Policy Unlocks Upfront Cash Payouts - Ad
The U.S. has collected $15B from Trump's tariffs - and now, thanks to Title 15, you could claim your own $100-$1,000 instant upfront cash payouts. No stocks needed. Use your phone and this income technique to collect upfront payouts now.
Texas Judge Blocks Biden-Era Rule Meant To Erase $49 Billion In Medical Debt From Credit Reports
A judge blocked a Biden-era rule that would have removed medical debt from credit reports, siding with industry arguments that the agency overstepped its authority.
Beat the heat with these cooling gadgets and wearables
You can only sit in front of the fridge with the door open for so long.
Unveil the 365X Crypto Secret - Replay Disappearing Soon! - Ad
Only 12 hours left! Watch the replay of the "365x Return in 90 Days" crypto Workshop before it's gone. Discover Joel and Adam's 4-part system, real success stories, and how to start mirroring their trades. This is your last chance-don't miss out.
'The Salt Path:' A book that captured the hearts of millions, but now mired in controversy
LONDON (AP) — “The Salt Path” is a memoir of resilience and courage that captured the hearts of millions and which was subsequently adapted for the big screen, with actors Gillian Anderson and Jason Isaacs taking the lead roles.
Making healthy snacks a habit when afternoon energy slumps strike at work
NEW YORK (AP) — When Claire Paré was a classroom teacher, working in a setting where every minute, down to the bathroom breaks, was scheduled, she brought granola bars, and protein shakes to school so she’d be prepared when hunger hits.
Revived Wartime Resource May Soon Power Everything from Bullets to Batteries - Ad
This overlooked metal isn't just for the battlefield anymore. It's part of the future energy grid, too. This could be a rare early-stage play in a market that's heating up fast.
UnitedHealth Slammed With Another Lawsuit Over $119 Billion Stock Plunge
UnitedHealth now faces three shareholder lawsuits alleging the company's leadership caused harm to investors.
UnitedHealth Former Staff Reveal Dark Secrets Of Medicare Billing Practices
UnitedHealth is under federal investigation for Medicare billing practices, including use of nurses and software to log diagnoses that led to billions in extra payments.
China is Tightening Critical Metal Supply-Investors Wondering Who Will Step Up - Ad
This metal powers everything from munitions to batteries. But with China imposing export controls, the West is scrambling for supply. One tiny firm may control a key N. American site-and investors are watching closely.
Swiss medicines authority issues first approval for antimalarial drug for treatment of infants
GENEVA (AP) — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of lives — nearly all in Africa — each year.
Novartis Gets Swiss Approval For First Malaria Drug For Babies
Novartis' Coartem Baby wins Swiss approval as the first malaria drug for newborns under 5 kg, offering safer dosing and easier administration.
Copper's Rally Is Back. This $31M Junior Is Sitting on a Potential Fortune - Ad
A high-grade copper-gold discovery in Quebec just delivered extremely high grade intercepts. Valuation? Just $31M. With copper breaking out, the timing here could be perfect. Get the symbol here.
Apogee Therapeutics' Eczema Drug Provides Rapid Itch Relief In Phase 2 Trial
Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B is ongoing.
Nearly 368,000 pounds of Oscar Mayer turkey bacon recalled over possible listeria contamination
Nearly 368,000 pounds of Oscar Mayer turkey bacon products are being recalled over possible contamination with , federal health officials said Wednesday.
Copper's Spiking - And This Junior Has the Grades to Match - Ad
Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.
FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls
FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare neuromuscular disease.
Severe heat waves hit Southern Europe as local authorities warn against wildfire risks
ROME (AP) — Major heat waves across Southern Europe have pushed temperatures above 40 C (104 F) in countries including Italy, Spain and Greece, as local authorities issued fresh warnings against the risk of wildfires.
Bitcoin Just Crossed $120,000 ... How High Will It Go? - Ad
Weiss Ratings Crypto Expert, Juan Villaverde believes that 2025 will be the biggest year in crypto history and there is a new coin that he believes could change Bitcoin and Ethereum from the "Big Two" to the "Big Three" this year.
Business News Digest
AP Business Digest
Thailand starts banning the sale of cannabis without a prescription
BANGKOK (AP) — Thailand has started banning the sale of cannabis to those without a prescription, three years after becoming the first country in Asia to decriminalize the plant.
This Tiny Tech Stock Could Be the Next Big Platform Play - Ad
One under-the-radar company is embedding intelligence into everyday glass-already powering Ferraris, aircraft, and city buses with adaptive surfaces and vision systems. It's not just a product. It's a platform.
Viatris Eye Drops Data Shows Promise For Blurred Near Vision
Viatris and Opus Genetics report MR-141 met efficacy and safety goals in Phase 3 VEGA-3 trial for presbyopia, with strong patient-reported benefits.
Key Medicaid provision in Trump's big bill found to violate Senate rules
WASHINGTON (AP) — The Senate parliamentarian has advised that a key that is central to President Donald Trump's does not adhere to procedural rules, delivering a crucial blow Republicans rushing to finish the massive package this week.
Gold Just Hit Another Record. This Junior Could Be Next. - Ad
This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.
Louisiana files lawsuits alleging pharmaceutical giant CVS deceived customers in text messages
NEW ORLEANS (AP) — Louisiana filed several lawsuits accusing pharmaceutical giant CVS of abusing customer information and using its dominant market position to drive up drug costs and unfairly undermine independent pharmacies, the state’s attorney general said Tuesday.
2 Florida men are accused of stealing millions from trust fund for people with special needs
Two Florida men have been indicted in what prosecutors describe as a scheme to steal more than $100 million from a nonprofit that managed funds for people with disabilities and special needs.
Most Bitcoin Holders Have No Idea This Exists - Ad
I call it "Bitcoin Skimming"... and it allows you to "skim" cash into your account thanks to 2025's surging Bitcoin market. You don't have to buy or sell Bitcoin. Not one single penny's worth. In my latest video briefing, I'll give you everything you need to "skim" your first payout -- and it won't cost you a penny.
FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due.
Health insurers promise to improve coverage reviews that prompt delays and complaints
The nation’s major health insurers are promising to scale back and improve a widely despised practice that leads to care delays and complications.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.